Coronavirus Update: EU Demands AstraZeneca Meets Its Vaccines Commitments After Supply Warning
Row Comes Ahead Of Expected CHMP Decision
Executive Summary
Plus Takeda starts vaccine trial in Japan and South Korea clears Celltrion's antibody therapeutic.
You may also be interested in...
Celltrion Antibody Becomes First Home-Grown COVID-19 Drug Approval In Korea
Helped by government support for the development of COVID-19 drugs and vaccines, Celltrion’s monoclonal antibody becomes the first therapeutic for the disease to be officially approved in South Korea.
AstraZeneca Vaccine May Only Gain EU Approval In Under 70s
AZ and the EU are at loggerheads over supplies of the COVID-19 vaccine. On top of that, its marketing authorization will present dilemmas.
Moderna Takes The Lead With Plan To Tackle New COVID-19 Variants
Moderna has unveiled plans to develop a new booster vaccine, tweaked to meet the threat posed by the South African strain.
Existing Subscriber?
Sign in to continue reading.
Need a specific report? 1000+ reports available
Buy Reports
Need a specific report? 1000+ reports available
Buy Reports